CLASS II Device recall · Reported 27 Dec 2017 · FDA Enforcement Report

Azurion 3 M12, Azurion 3 M15, Allura R9 7 M12 recalled

Philips Electronics North America is recalling Azurion 3 M12, Azurion 3 M15, Allura R9 7 M12, Allura R9 M20, Azurion 7 M12, Azurion 7, distributed nationwide in the US. The recall was initiated on 18 Aug 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes7220063, 722064, 22065, 722066, 722078, 722079
Quantity recalled157

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0255-2018
FDA event ID
78739
Recalling firm
Philips Electronics North America, Andover, MA
Classification
Class II
Status
Terminated
Recall initiated
18 Aug 2017
FDA classified
18 Dec 2017
Reported
27 Dec 2017
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Foreign Material

Timeline

18 Aug 2017Recall initiated by company
18 Dec 2017Classified by FDA+122 days
27 Dec 2017Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

When using the downscale option with the Allura R9 system or Azurion R1.1 system, the measurements performed using the QA Basic Measurement tool will not be correctly exported to the external DICOM destination.

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Azurion 3 M12, Azurion 3 M15, Allura R9 7 M12, Allura R9 M20, Azurion 7 M12, Azurion 7 M20 The Allura Xper series is intended for use on human patients to perform: Vascular, cardiovascular and neurovascular imaging applications, including diagnostic, interventional and minimally invasive procedures. This includes, e.g., peripheral, cerebral, thoracic and abdominal angiography, as well as PTAs, stent placements, embolisations and thrombolysis. Cardiac imaging applications including diagnostics, interventional and minimally invasive procedures ( such as PTCA, stent placing, atherectomies), pacemaker implantations, and electrophysiology (EP) Non-vascular interventions such as drainages, biopsies and vertebroplastics procedures The Azurion series (within the limits of the used Operation Room table) are intended for use to perform: Image guidance in diagnostic, interventional and minimally invasive surgery procedures for the following clinical application areas: vascular, non-vascular, cardiovascular and neuro procedures. Cardiac imaging applications including diagnostics, interventional and minimally invasive surgery procedures.

Where it was distributed

Worldwide Distribution - USA (nationwide) Distribution.

Nationwide

Questions about this recall

Why was it recalled?

When using the downscale option with the Allura R9 system or Azurion R1.1 system, the measurements performed using the QA Basic Measurement tool will not be correctly exported to the external DICOM destination.

Which lots are affected?

7220063, 722064, 22065, 722066, 722078, 722079

Where was it sold?

Worldwide Distribution - USA (nationwide) Distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Philips Electronics North America

All 160

Other Pacemakers & Defibrillators recalls

All 494